Search Results (106)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Primary upper tract urothelial carcinoma with thyroid-like features. | Academic Article |
Why?
|
| Case Report of a Rare Presentation of Urothelial Carcinoma With Gastric Metastasis. | Academic Article |
Why?
|
| ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings. | Academic Article |
Why?
|
| Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation. | Academic Article |
Why?
|
| Incidental Gynecologic Tract Neoplasms in Women Undergoing Anterior Pelvic Exenteration for Urothelial Carcinoma. | Academic Article |
Why?
|
| Intermediate followup of hand assisted laparoscopic nephroureterectomy for urothelial carcinoma: factors associated with outcomes. | Academic Article |
Why?
|
| Plasmacytoid Urothelial Carcinoma: An Unusual Variant That Warrants Aggressive Management and Critical Distinction on Transurethral Resections. | Academic Article |
Why?
|
| Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis. | Academic Article |
Why?
|
| Pseudoangiosarcomatous urothelial carcinoma of the urinary bladder. | Academic Article |
Why?
|
| Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer. | Academic Article |
Why?
|
| Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. | Academic Article |
Why?
|
| Utilization and Outcomes of Nephroureterectomy for Upper Tract Urothelial Carcinoma by Surgical Approach. | Academic Article |
Why?
|
| Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma. | Academic Article |
Why?
|
| Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers. | Academic Article |
Why?
|
| Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure. | Academic Article |
Why?
|